{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:03:02Z","timestamp":1788382982272,"version":"build-2803163510"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.parkreldis.2016.07.001","type":"journal-article","created":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T00:39:53Z","timestamp":1467765593000},"page":"73-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Drooling in Parkinson\u2019s disease: A randomized controlled trial of incobotulinum toxin A and meta-analysis of Botulinum toxins"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9412-7349","authenticated-orcid":false,"given":"Pushpa","family":"Narayanaswami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Geisbush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Tarulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Raynor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Tarsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Gronseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2016.07.001_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/mds.870060211","article-title":"Gastrointestinal symptoms in Parkinson\u2019s disease","volume":"6","author":"Edwards","year":"1991","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.07.001_bib2","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.parkreldis.2014.08.013","article-title":"Drooling in Parkinson\u2019s disease: a review","volume":"20","author":"Srivanitchapoom","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2016.07.001_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clineuro.2003.10.012","article-title":"Ultrasound-guided versus \u2019blind\u2019 intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson\u2019s disease","volume":"106","author":"Dogu","year":"2004","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.parkreldis.2016.07.001_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mds.23473","article-title":"Botulinum toxin A versus B in sialorrhea: a prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson\u2019s disease","volume":"26","author":"Guidubaldi","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.07.001_bib5","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/mds.20793","article-title":"Botulinum toxin type A for drooling in Parkinson\u2019s disease: a double-blind, randomized, placebo-controlled study","volume":"21","author":"Lagalla","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.07.001_bib6","first-page":"563","article-title":"Long-lasting benefits of botulinum toxin type B in Parkinson\u2019s disease-related drooling","volume":"256","author":"Lagalla","year":"2009","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.parkreldis.2016.07.001_bib7","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1212\/WNL.61.9.1279","article-title":"A\u00a0randomized trial of botulinum toxin A for treatment of drooling","volume":"61","author":"Lipp","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2016.07.001_bib8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/mds.10420","article-title":"Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism","volume":"18","author":"Mancini","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.07.001_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jns.2006.11.015","article-title":"Does botulinum toxin decrease frequency and severity of sialorrhea in Parkinson\u2019s disease?","volume":"253","author":"Nobrega","year":"2007","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2016.07.001_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1212\/01.WNL.0000101713.81253.4C","article-title":"A\u00a0double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson\u2019s disease","volume":"62","author":"Ondo","year":"2004","journal-title":"Neurology"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.parkreldis.2016.07.001_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1468-1331.2009.02877.x","article-title":"Routine use of Xeomin in patients previously treated with Botox: long term results","volume":"16","author":"Dressler","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.parkreldis.2016.07.001_bib12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1212\/WNL.54.1.244","article-title":"Botulinum toxin A as treatment for drooling saliva in PD","volume":"54","author":"Pal","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2016.07.001_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/mds.23929","article-title":"Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson\u2019s disease: a prospective double-blind trial","volume":"27","author":"Chinnapongse","year":"2012","journal-title":"Mov. Disord."}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802016302449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802016302449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T14:20:11Z","timestamp":1536589211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802016302449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":13,"alternative-id":["S1353802016302449"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2016.07.001","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drooling in Parkinson\u2019s disease: A randomized controlled trial of incobotulinum toxin A and meta-analysis of Botulinum toxins","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2016.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}